Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switching from rHuEPO to R744 in Hemodialysis Patients
NCT00433888Phase 3Completed
- Sponsor
- Chugai Pharmaceutical Co., Ltd.
- Start
- Jan 2007
- Primary completion
- Jul 2008
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of Epoetin alfa RB in anemia of chronic kidney disease, sponsored by Chugai Pharmaceutical Co., Ltd.. Started Jan 2007; status: completed.
02
Drugs
Epoetin alfa RB
03
Conditions
anemia of chronic kidney disease
Beyond the preview
Go deeper on NCT00433888.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00433888.